Health and Fitness Health and Fitness
Thu, November 18, 2010
Wed, November 17, 2010
Tue, November 16, 2010
Mon, November 15, 2010
Sun, November 14, 2010
Fri, November 12, 2010
Thu, November 11, 2010
Wed, November 10, 2010
Tue, November 9, 2010
Mon, November 8, 2010
Sun, November 7, 2010
Sat, November 6, 2010
Fri, November 5, 2010
Thu, November 4, 2010
Wed, November 3, 2010
Tue, November 2, 2010
Mon, November 1, 2010

Synta Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference


//health-fitness.news-articles.net/content/2010/ .. apital-markets-annual-healthcare-conference.html
Published in Health and Fitness on Tuesday, November 9th 2010 at 13:36 GMT by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Lazard Capital Markets 7th Annual Healthcare Conference on Tuesday, November 16 at 2:10 p.m. (ET) in New York.

A live audio webcast and replay of the presentation will be available at [ http://www.wsw.com/webcast/lz8/snta/ ].

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit [ www.syntapharma.com ].


Publication Contributing Sources